Effect of α-Hemolysin Producing E. coli in Two Different Mouse Strains in a DSS Model of Inflammatory Bowel Disease

Hengameh Chloé Mirsepasi-Lauridsen1,2,3,4, Carsten Struve1, Andreas Munk Petersen5,6

  • 1Department of Bacteria, Parasites and Fungi, Statens Serum Institut, 2300 Copenhagen, Denmark.

Microorganisms
|December 16, 2020
PubMed
Abstract

Insights

Ulcerative colitis (UC)-associated Escherichia coli p19A colonizes mouse intestines and causes extra-intestinal infections. Alpha-hemolysin is crucial for this pathogenesis, as hemolysin mutants showed reduced inflammation.

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Phylogroup B2 Escherichia coli strains are linked to ulcerative colitis (UC).
  • The specific role of UC-associated E. coli p19A and alpha hemolysin in UC pathogenesis requires further investigation.

Purpose of the Study:

  • To compare the colonization of UC-associated E. coli p19A in different mouse strains.
  • To investigate the role of alpha hemolysin in a dextran sulfate sodium (DSS)-induced UC mouse model.

Main Methods:

  • Sigirr-/- and C57BL/6 mice were used, with UC induced by DSS in drinking water.
  • Mice were pre-treated with ciprofloxacin and orally gavaged with wild-type p19A, alpha-hemolysin knockout p19A (p19A-ΔhlyI II), or DH10B E. coli.
  • Colonization was visualized using an in vivo imaging system.

Main Results:

  • Wild-type p19A colonized the colon, ileum, Peyer's patches, liver, and spleen in both mouse strains.
  • Survival rates were significantly higher in Sigirr-/- mice (29%) compared to C57BL/6 mice (99%) infected with p19A WT by day 4 post-infection.

Conclusions:

  • UC-associated E. coli p19A colonizes DSS-treated mouse intestines and leads to extra-intestinal infections.
  • Alpha hemolysin is a key virulence factor, as hemolysin mutants failed to induce similar levels of inflammation.

Related Concept Videos